Long-term metabolic outcome and quality of life after laparoscopic adjustable gastric banding in obese patients with type 2 diabetes mellitus or impaired fasting glucose
Article first published online: 19 APR 2010
Copyright © 2010 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
British Journal of Surgery
Volume 97, Issue 6, pages 884–891, June 2010
How to Cite
Caiazzo, R., Arnalsteen, L., Pigeyre, M., Dezfoulian, G., Verkindt, H., Kirkby-Bott, J., Mathurin, P., Fontaine, P., Romon, M. and Pattou, F. (2010), Long-term metabolic outcome and quality of life after laparoscopic adjustable gastric banding in obese patients with type 2 diabetes mellitus or impaired fasting glucose. Br J Surg, 97: 884–891. doi: 10.1002/bjs.6993
- Issue published online: 10 MAY 2010
- Article first published online: 19 APR 2010
- Manuscript Accepted: 10 DEC 2009
- French Ministry of Health
- Conseil Régional Nord-Pas de Calais
The long-term outcome of type 2 diabetes mellitus after laparoscopic adjustable gastric banding (LAGB) is unknown.
A longitudinal cohort study was undertaken of patients with grade 3 obesity and type 2 diabetes or impaired fasting glucose (IFG) undergoing LAGB. Metabolic outcomes and quality of life (QoL) were assessed before and 5 years after LAGB.
At 5 years, data for 22 out of 23 patients with type 2 diabetes and 51 out of 53 with IFG were available. Mean(s.d.) excess weight loss was 41(25) and 41(27) per cent in patients with type 2 diabetes and IFG respectively, and was associated with a significant decrease in haemoglobin (Hb) A1c, fasting and postprandial blood glucose, insulin and triglyceride levels, and in liver steatosis. There were significant increases in insulin sensitivity, β-cell function, disposition index, high-density lipoprotein-cholesterol and QoL (Nottingham Health Profile). Good metabolic control (HbA1c 7 per cent or less) was obtained in 13 diabetic patients, but complete diabetes remission was maintained in only four. Longer duration of diabetes, and poor preoperative glucose control and β-cell function at baseline were associated with a less favourable outcome.
LAGB improved metabolic outcomes and QoL in patients with grade 3 obesity with IFG or type 2 diabetes but rarely led to prolonged remission in long-standing diabetes. Copyright © 2010 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.